Effect of Prescribed Cardiac Rehabilitation in Patients With Advanced Heart Failure or Ventricular Assist Device
NCT ID: NCT04696900
Last Updated: 2021-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
14 participants
INTERVENTIONAL
2020-06-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise training
14 participants will absolve a prescribed exercise training for 12 months.
Exercise training
exercise training in an approved rehabilitation program
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise training
exercise training in an approved rehabilitation program
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* written informed consent
* chronic end-stage systolic heart failure with or without ventricular assist device
* clinically stable for at least 6 weeks
* prescription of cardiac rehabilitation
Exclusion Criteria
* lack of knowledge of German to fully understand study information
* pregnancy, pre-menopausal women
* participation in the rehabilitation program \< 80%
* contraindications of cardiopulmonary exercise testing on an ergometer
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
German Heart Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
I A Just
Role: PRINCIPAL_INVESTIGATOR
German Heart Institute
F Schoenrath
Role: PRINCIPAL_INVESTIGATOR
German Heart Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
German Heart Institute
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
I A Just
Role: primary
F Schoenrath
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REHAB-HF/VAD
Identifier Type: -
Identifier Source: org_study_id